Metabolic Syndrome Market Needs Uniform Definition, Effective Therapies
Executive Summary
Drug companies should attempt to build a market for metabolic syndrome by getting information in the clinical studies section of labeling as a precursor to a specific indication
You may also be interested in...
Obesity Guidance Should Be More Lenient On Indications, Firms Tell FDA
A stipulation that patients should fail lifestyle modifications before they are eligible to enroll in clinical trials for obesity drugs needs to be modified, according to industry comments on an FDA draft guidance on development of weight management drugs
Obesity Guidance Should Be More Lenient On Indications, Firms Tell FDA
A stipulation that patients should fail lifestyle modifications before they are eligible to enroll in clinical trials for obesity drugs needs to be modified, according to industry comments on an FDA draft guidance on development of weight management drugs
FDA Says No To Metabolic Syndrome; New Obesity Guidance Takes Hard Line
FDA currently views metabolic syndrome as "not necessarily" a distinct disease entity, according to the agency's draft guidance on obesity products